First Amended Combined Liquidation Plan and Disclosure Statement Approved on Interim Basis for Clarus Therapeutics Holdings, Inc.

The US Bankruptcy Court approved the first amended combined liquidation plan and disclosure statement on interim basis for solicitation purpose of Clarus Therapeutics Holdings, Inc. on December 22, 2022. The debtor had filed its amended disclosure statement in the Court on December 21, 2022. December 22, 2022 has been fixed as voting record date.

The deadline to vote on the plan and the plan objection deadline is February 1, ?2023. The confirmation hearing for the plan has been scheduled for February 8, 2023.